A novel combination of two oral drugs can help leukemia patients survive and recover from their disease, a new study shows. Adults may have CLL developing in their bodies for years without knowing they have it and the survival rate is higher than other forms of leukemia, about 83 percent. Doctors rely on certain genetic markers - abnormalities in a person's DNA - to identify chronic leukemia patients. After previous research showed that the combination of ibrutinib and venetoclax (two existing leukemia drugs) worked well in a lab setting, they took this treatment to patients. However, because the trial overwhelmingly looked at white leukemia patients, it may have missed side effects or complications for patients of color.

Source: Daily Mail June 10, 2021 15:01 UTC